Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 May 6:13:54.
doi: 10.1186/1745-6215-13-54.

Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II-trial): study protocol for a randomised controlled trial

Ronald M van Dam  1 , Edgar M Wong-Lun-Hing, Gerard J P van Breukelen, Jan H M B Stoot, Joost R van der Vorst, Marc H A Bemelmans, Steven W M Olde Damink, Kristoffer Lassen, Cornelis H C Dejong; ORANGE II Study Group
Collaborators, Affiliations
Randomized Controlled Trial

Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II-trial): study protocol for a randomised controlled trial

Ronald M van Dam et al. Trials. .

Abstract

Background: The use of lLaparoscopic liver resection in terms of time to functional recovery, length of hospital stay (LOS), long-term abdominal wall hernias, costs and quality of life (QOL) has never been studied in a randomised controlled trial. Therefore, this is the subject of the international multicentre randomised controlled ORANGE II trial.

Methods: Patients eligible for left lateral sectionectomy (LLS) of the liver will be recruited and randomised at the outpatient clinic. All randomised patients will undergo surgery in the setting of an ERAS programme. The experimental design produces two randomised arms (open and laparoscopic LLS) and a prospective registry. The prospective registry will be based on patients that cannot be randomised because of the explicit treatment preference of the patient or surgeon, or because of ineligibility (not meeting the in- and exclusion criteria) for randomisation in this trial. Therefore, all non-randomised patients undergoing LLS will be approached to participate in the prospective registry, thereby allowing acquisition of an uninterrupted prospective series of patients. The primary endpoint of the ORANGE II trial is time to functional recovery. Secondary endpoints are postoperative LOS, percentage readmission, (liver-specific) morbidity, QOL, body image and cosmetic result, hospital and societal costs over 1 year, and long-term incidence of incisional hernias. It will be assumed that in patients undergoing laparoscopic LLS, length of hospital stay can be reduced by two days. A sample size of 55 patients in each randomisation arm has been calculated to detect a 2-day reduction in LOS (90% power and α = 0.05 (two-tailed)).The ORANGE II trial is a multicenter randomised controlled trial that will provide evidence on the merits of laparoscopic surgery in patients undergoing LLS within an enhanced recovery ERAS programme.

Trial registration: ClinicalTrials.gov NCT00874224.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Orange II-Trial Flowchart.
Figure 2
Figure 2
Daily guideline of postoperative care of patients undergoing a hepatectomy in the ERAS programme.
See this image and copyright information in PMC

References

    1. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer. 2002;38(7):1023–1033. doi: 10.1016/S0959-8049(02)00059-X. - DOI - PubMed
    1. Cuesta MA, Meijer S, Paul MA, de Brauw LM. Limited laparoscopic liver resection of benign tumors guided by laparoscopic ultrasonography: report of two cases. Surg Laparosc Endosc. 1995;5(5):396–401. - PubMed
    1. Carswell KA, Sagias FG, Murgatroyd B, Rela M, Heaton L, Patel AG. et al. Laparoscopic versus open left lateral segmentectomy. BMC Surg. 2009;9(14):9. - PMC - PubMed
    1. Vigano L, Tayar C, Laurent A, Cherqui D. Laparoscopic liver resection: a systematic review. J Hepatobiliary Pancreat Surg. 2009;16(4):410–421. doi: 10.1007/s00534-009-0120-8. - DOI - PubMed
    1. Cherqui D. Laparoscopic liver resection. Br J Surg. 2003;90(6):644–646. doi: 10.1002/bjs.4197. - DOI - PubMed

Publication types

MeSH terms

Associated data